Jordan Erica

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$9,096.30

Insider Activity of Jordan Erica

According to the SEC Form 4 filings, Jordan Erica, being in a position of

  1. Chief Commercial Officer at Revance Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2392 shares for $9,096,
    over all time since 2024-04-16, has bought 0 shares, and sold 2392 shares for $9,096.

The largest sale of all time was on 2024-04-16 and amounted to 2392 shares of Revance Therapeutics, Inc. for $9,096.

Biography of Jordan Erica

No biography is available at this moment.

2024-04-16SaleRevance Therapeutics, Inc.
RVNC
Chief Commercial Officer
2,392
0.0023%
$3.80$9,096-3.41%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.